LATE CELL CYCLE SIGNATURES STRATIFY GEMDOCE RESPONSES FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Gabrielson, Andrew
Epstein, Gabriel
Feng, Mingxiao
Patel, Sunil
Kates, Max
Choi, Woonyoung
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP14-16
引用
收藏
页码：E188 / E189
页数：2
相关论文
共 50 条
  • [31] ELICITATION OF HEALTH STATE UTILITIES ASSOCIATED PROGRESSION FROM BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) HEALTH STATES
    Cooper, O.
    Rentz, A.
    Piglowska, N.
    Smith, C.
    Jakobsen, J.
    Catto, J.
    Niegisch, G.
    Ghatnekar, O.
    Swinburn, P.
    VALUE IN HEALTH, 2022, 25 (07) : S288 - S288
  • [32] NON-MUSCLE INVASIVE BLADDER CANCER RESISTANT TO BCG
    Turker, Polat
    Turkeri, Levent
    ARCHIVOS ESPANOLES DE UROLOGIA, 2013, 66 (09): : 833 - 840
  • [33] Novel immunotherapeutic options for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
    Hannouneh, Zein Alabdin
    Hijazi, Amjad
    Alsaleem, Alaa Aldeen
    Hami, Siwan
    Kheyrbek, Nina
    Tanous, Fadi
    Khaddour, Karam
    Abbas, Abdulfattah
    Alshehabi, Zuheir
    CANCER MEDICINE, 2023, 12 (24): : 21944 - 21968
  • [34] Re: IL-15 Superagonist NAI in BCG-Unresponsive Non-muscle-invasive Bladder Cancer
    Suderman, Jonathan
    St-Laurent, Marie-Pier
    Black, Peter C.
    EUROPEAN UROLOGY, 2023, 83 (06) : 581 - 581
  • [35] Safety of Hyperthermic IntraVEsical Chemotherapy (HIVEC) for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
    Marquette, T.
    Walz, J.
    Rybikowski, S.
    Maubon, T.
    Branger, N.
    Fakhfakh, S.
    Verde, K. L.
    Dermeche, S.
    Gravis, G.
    Pignot, G.
    PROGRES EN UROLOGIE, 2020, 30 (01): : 35 - 40
  • [36] Required efficacy for novel therapies in BCG-unresponsive non-muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes?
    Wettstein, Marian S.
    Naimark, David
    Hermanns, Thomas
    Herrera-Caceres, Jaime O.
    Ahmad, Ardalan
    Jewett, Michael A. S.
    Kulkarni, Girish S.
    CANCER MEDICINE, 2020, 9 (10): : 3287 - 3296
  • [37] BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets
    Claps, Francesco
    Pavan, Nicola
    Ongaro, Luca
    Tierno, Domenico
    Grassi, Gabriele
    Trombetta, Carlo
    Tulone, Gabriele
    Simonato, Alchiede
    Bartoletti, Riccardo
    Mertens, Laura S.
    van Rhijn, Bas W. G.
    Mir, Maria Carmen
    Scaggiante, Bruna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [38] ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INTRAVESICAL BLADDER SPARING THERAPY COMPARED TO UPFRONT RADICAL CYSTECTOMY IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Drupad, Annapureddy
    Jacob, Taylor
    Jeffrey, Howard
    Solomon, Woldu L.
    Yair, Lotan
    Shen, Tan Wei
    Ashish, Kamat
    Ian M, McElree
    Vignesh, Packiam T.
    Michael, O'Donnell
    Davaro, Facundo
    Roger, Li
    Kendrick, Yim
    Mark, Preston A.
    Stephen, Harrington
    Elizabeth, Dyer
    Jay, Raman
    Anna, Black
    Peter, Black
    Pratik, Kanabur
    Seth, Lerner
    Mathieu, Roumiguie
    Gary, Steinberg
    William, Huang
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S52 - S53
  • [39] The effectiveness and value of nadofaragene firadenovec, oportuzumab monatox, and pembrolizumab for BCG-unresponsive non-muscle-invasive bladder cancer
    Beinfeld, Molly
    Atlas, Steven J.
    Touchette, Daniel
    McKenna, Avery
    Rind, David
    Pearson, Steven D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (06): : 797 - 804
  • [40] Intravesical BCG therapy for non-muscle invasive bladder cancer
    Figurin, K. M.
    ONKOUROLOGIYA, 2012, 8 (01): : 14 - 22
12345